CBRC History

The MGH/Harvard Cutaneous Biology Research Center (CBRC) was inaugurated October 1, 1989 as a result of an Agreement between Massachusetts General Hospital and Shiseido Company Ltd. (Shiseido) which had been signed August 3, 1989.

In the establishment of the CBRC, an important caveat was recognized: high-caliber academic scientists "could not be recruited unless the commitment was primarily to basic research."

The emphasis on basic research has continued with in later years a growing expertise in the transition of intellectual property to applied research. The original agreement was for a period of ten years. This was extended under the same understandings; first in 1995 to 2004; and again in 1998 to 2009 with some caveats at that time.

While general non-directional core funding from Shiseido forms a major portion of CBRC support, additional funding from the National Institutes of Health (NIH) and other extramural agencies is critical.

Back to Top